Outbreaks of red-spotted grouper nervous necrosis virus (RGNNV) infection have constrained pond-based farming of giant grouper (Epinephelus lanceolatus) in Australia. Speckled-blue grouper (E. cyanopodus) is being explored as an alternative species and appears to have tolerance to RGNNV, whereby fish do not show signs of RGNNV infection even when co-cultured with infected giant grouper. In some farmed fish species such as barramundi (Lates calcarifer), RGNNV tolerance increases as the immune system matures with age. The current study investigated RGNNV tolerance in speckled-blue grouper and assessed whether the tolerance was age-dependent.
Speckled-blue grouper and giant grouper were experimentally challenged at 7-, 8-, 9-, and 10-weeks post hatch (wph) via intramuscular injection with an RGNNV inoculum (~2.3 × 103 RGNNV RNA copies g-1 body weight). Fish were euthanised either upon observation of clinical signs or at 4 weeks post-challenge. Brain, eyes, and mucous samples were collected for detection and quantification of RGNNV genomic RNA by RT-qPCR. Post-challenge morbidity in speckled-blue grouper was low (~14%) in the 7-8 wph and 0% in the 9-10 wph group, contrasting with consistently high morbidity (80-100%) in all age groups of giant grouper. RGNNV detection frequency in speckled-blue grouper tissue samples decreased with increasing fish age, however, RGNNV copy numbers in RGNNV-positive samples were consistent across age groups. The findings of the current study demonstrated that speckled-blue grouper develops tolerance to RGNNV in an age-dependent manner, with reduced morbidity rate and RGNNV detection (%) in tissues observed after 9 wph. The results support the potential of speckled-blue grouper as a more RGNNV-tolerant candidate for aquaculture in situations where RGNNV is endemic.